患有和有负面健康事件史的人的自我管理 (SMART):一个随机对照的有效性试验
Martha Sajatovic1, Gena R Ghearing2, Maegan Tyrrell2
1Department of Psychiatry and of Neurology, Neurological & Behavioral Outcomes Center, Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, Cleveland, OH, USA.
Epilepsy & behavior : E&B
|May 24, 2025
概括
智能自我管理 (ESM) 课程改善了患者的负面健康事件和发作减少. 参与者还显示抑郁症状减少,自我效能和生活质量提高.
科学领域:
- 神经学 神经学
- 公共卫生 公共卫生
- 行为科学 行为科学
背景情况:
- 的自我管理 (ESM) 对于改善患者 (PWE) 的结果至关重要.
- 负面的健康事件 (NHE),包括发作,急诊,住院和自我伤害,显著影响PWE.
- 需要有效的自我管理策略来缓解NHE并提高生活质量.
研究的目的:
- 评估SMART自治 (ESM) 课程与等候名单 (WL) 控制相比的有效性.
- 评估SMART计划对PWE负面健康事件 (NHE) 和发作频率的影响.
- 检查SMART对心理健康,生活质量和自我管理技能的影响.
主要方法:
- 一项为期2个地点6个月的随机对照试验,涉及160名患者 (PWE),他们在过去6个月中至少经历过一次NHE.
- 参与者被随机分配到SMART ESM课程或6个月候选名单 (WL) 控制组.
- 主要结局包括NHE和数的变化;次要结局评估了抑郁症 (PHQ-9),生活质量 (QOLIE-31),自我管理 (ESMS),自我有效性 (ESES) 和耻辱感 (ESS).
主要成果:
- 与WL组相比,SMART组在NHE中取得10-30%的改善的可能性显著更大 (p <0.05).
- 智能干预与发作频率的显著减少,抑郁症状的改善 (PHQ-9),自我管理 (ESMS) 和自我有效性 (ESES) 的增强有关.
- 此外,QOLIE-31的焦虑和社会功能方面也得到了改善.
结论:
- 智能ESM课程有效改善了患者的负面健康事件,控制和抑郁症状.
- 参与SMART计划的参与者表现出增强的自我管理能力,自我效能和特定的生活质量指标.
- 建议将SMART等有效的ESM计划集成到PWE的综合护理模型中,以改善患者的治疗结果.
更多相关视频
08:53Randomized, Triple-Blind, and Parallel-Controlled Trial of Transcranial Direct Current Stimulation for Cognitive Rehabilitation after Stroke
Published on: June 6, 2025
1.6K
09:06Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
Published on: December 22, 2016
10.0K
相关概念视频
01:24Epilepsy and Seizures: Overview
1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K
01:30Electroconvulsive Therapy
927
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
927
01:20Antiepileptic Drugs: Potassium Channel Activators
637
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
637